NCT04678908 - A Study of Injection HB0025 in Patients With Advanced Solid Tumors | Biotech Hunter

Enrollment

154

Participants

Timeline

Start Date

March 10, 2021

Primary Completion Date

February 2, 2024

Study Completion Date

May 23, 2024

Conditions

Tumor, Subjects

Interventions

DRUG

HB0025

Patients will be assigned to dose regimens in the order of enrollment, and they will receive their assigned fixed dose of HB0025 via intravenous infusion.

Trial Locations (6)

78229

RECRUITING

NEXT Oncology, San Antonio

201210

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

233000

RECRUITING

The First Affiliated Hospital of Bengbu Medical College, Bengbu

250000

RECRUITING

Central Hospital Affiliated to ShanDong First Medical University, Jinan

RECRUITING

Qilu Hospital of Shandong University, Jinan

726000

RECRUITING

Linyi Cancer Hospital, Linyi